Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.
Saved in:
| Title: | Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation. |
|---|---|
| Authors: | Gong W; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Chen X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Shi T; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Shao X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., An X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Qin J; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Chen X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China., Jiang Q; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.; Laboratory for Bone and Joint Disease, Model Animal Research Center (MARC), Medical School, Nanjing University, Nanjing, China., Guo B; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Oct 01; Vol. 12, pp. 727808. Date of Electronic Publication: 2021 Oct 01 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34658868 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gong+W%22">Gong W</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Shi+T%22">Shi T</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Shao+X%22">Shao X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22An+X%22">An X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Qin+J%22">Qin J</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Q%22">Jiang Q</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.; Laboratory for Bone and Joint Disease, Model Animal Research Center (MARC), Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Guo+B%22">Guo B</searchLink>; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Oct 01; Vol. 12, pp. 727808. <i>Date of Electronic Publication: </i>2021 Oct 01 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34658868 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2021.727808 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 727808 Titles: – TitleFull: Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gong W – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Shi T – PersonEntity: Name: NameFull: Shao X – PersonEntity: Name: NameFull: An X – PersonEntity: Name: NameFull: Qin J – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Jiang Q – PersonEntity: Name: NameFull: Guo B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2021 Oct 01 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |